Cargando…
Are we underestimating the lifelong benefits of therapy for obstructive sleep apnea?
Autores principales: | Berman, Alec M, Thosar, Saurabh S, Shea, Steven A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807943/ https://www.ncbi.nlm.nih.gov/pubmed/27051325 http://dx.doi.org/10.2147/NSS.S106224 |
Ejemplares similares
-
Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?
por: Schmickl, Christopher N., et al.
Publicado: (2022) -
Obstructive sleep apnea: Underestimated risk factor in sudden cardiac death in schizophrenia
por: Scorza, Fulvio A., et al.
Publicado: (2016) -
Opportunities for Cardiovascular Benefits in Treating Obstructive Sleep Apnea in the Secondary Prevention Scenario
por: Mazzotti, Diego R., et al.
Publicado: (2020) -
Obstructive sleep apnea and diabetes
por: Bloomgarden, Zachary
Publicado: (2023) -
Shorter Sleep Predicts Longer Subsequent Day Sedentary Duration in Healthy Midlife Adults, but Not in Those with Sleep Apnea
por: Thosar, Saurabh S, et al.
Publicado: (2021)